Long-Term Efficacy of Oral Treprostinil in Subjects with Pulmonary Arterial Hypertension: FREEDOM-EV Open-Label Extension Study

被引：0
|
作者：
White, R. J. [1 ]
Broderick, M. [2 ]
Deng, C. Q. [2 ]
Grover, R. [2 ]
Holdstock, L. [2 ]
Khan, A. [3 ]
Bohns Meyer, G. [4 ]
Ng, B. [5 ]
Pulido Zamudio, T. [6 ]
Saib, I. [2 ]
Sepulveda, P. [7 ]
机构：
[1] Univ Rochester, Rochester, NY USA
[2] United Therapeut, Durham, NC USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Ctr Hipertensao Pulmonar, Porto Alegre, RS, Brazil
[5] Nepean Hosp, Kingswood, NSW, Australia
[6] Inst Nacl Cardiol Call, Mexico City, DF, Mexico
[7] Catholic Univ Chile, Santiago, Chile
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2152
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ORAL TREPROSTINIL IMPROVES SURVIVAL IN FREEDOM-EV AND FREEDOM-EV OPEN-LABEL EXTENSION PARTICIPANTS WITH PULMONARY ARTERIAL HYPERTENSION
    White, R. James
    McConnell, John W.
    Waxman, Aaron B.
    Hage, Antoine
    Cadaret, Linda M.
    Balasubramanian, Vijay
    Lee, Dasom
    Seaman, Scott
    Broderick, Meredith
    Deng, C. Q.
    Rahaghi, Franck F.
    [J]. CHEST, 2023, 164 (04) : 5873A - 5875A
  • [2] ORAL TREPROSTINIL TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION PARTICIPANTS IN FREEDOM-EV AND THE FREEDOM-EV OPEN-LABEL EXTENSION STUDY
    White, R. James
    Pepke-Zaba, Joanna
    Balasubramanian, Vijay P.
    Elwing, Jean M.
    Mc Vonk, Madelon
    Rosenkranz, Stephan H.
    Cadaret, Linda M.
    Sahay, Sandeep
    Yu, Zaixin
    Holdstock, Louis
    Deng, C. Q.
    Seaman, Scott
    Broderick, Meredith
    Vizza, Carmine D. V.
    [J]. CHEST, 2022, 162 (04) : 2301A - 2303A
  • [3] ORAL TREPROSTINIL AS PART OF A TRIPLE-THERAPY REGIMEN FOR PULMONARY ARTERIAL HYPERTENSION: ANALYSIS FROM THE FREEDOM-EV OPEN-LABEL EXTENSION
    Elwing, Jean M.
    Rahaghi, Franck F.
    Hage, Antoine
    Vizza, Carmine D. V.
    Grunig, Ekkehard
    Wang, Kuo K.
    Holdstock, Louis
    Scott, C. Q. Deng
    Broderick, Seaman Meredith
    White, R. James
    [J]. CHEST, 2022, 162 (04) : 2363A - 2364A
  • [4] Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
    Ekkehard Grünig
    Franck Rahaghi
    Jean Elwing
    Carmine Dario Vizza
    Joanna Pepke-Zaba
    Jieyan Shen
    Hua Yao
    Antoine Hage
    Stephan Rosenkranz
    Madelon Vonk
    Vijay Balasubramanian
    Yang Yuanhua
    Zaixin Yu
    James Lordan
    Linda Cadaret
    Rob Grover
    Aliou Ousmanou
    Scott Seaman
    Chunqin Deng
    Meredith Broderick
    R. James White
    [J]. Advances in Therapy, 2024, 41 : 618 - 637
  • [5] An Open-Label Extension Trial Of Oral Treprostinil In Subjects With Pulmonary Arterial Hypertension
    White, R. J.
    Jing, Z. -C.
    Parikh, K.
    Bartolome, S.
    Allen, R. P.
    Xu, K. -F.
    Shapiro, S.
    Feldman, J.
    Crawford, K.
    Arneson, C.
    Laliberte, K.
    Tapson, V. F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [6] Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
    Gruenig, Ekkehard
    Rahaghi, Franck
    Elwing, Jean
    Vizza, Carmine Dario
    Pepke-Zaba, Joanna
    Shen, Jieyan
    Yao, Hua
    Hage, Antoine
    Rosenkranz, Stephan
    Vonk, Madelon
    Balasubramanian, Vijay
    Yang, Yuanhua
    Yu, Zaixin
    Lordan, James
    Cadaret, Linda
    Grover, Rob
    Ousmanou, Aliou
    Seaman, Scott
    Deng, Chunqin
    Broderick, Meredith
    White, R. James
    [J]. ADVANCES IN THERAPY, 2024, 41 (02) : 618 - 637
  • [7] Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension
    Benza, Raymond L.
    Seeger, Werner
    McLaughlin, Vallerie V.
    Channick, Richard N.
    Voswinckel, Robert
    Tapson, Victor F.
    Robbins, Ivan M.
    Olschewski, Horst
    Rubin, Lewis J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12): : 1327 - 1333
  • [8] TREATMENT BENEFITS ASSOCIATED WITH OPEN LABEL ORAL TREPROSTINIL AFTER CLINICAL WORSENING IN THE PHASE 3 FREEDOM-EV STUDY FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    White, R.
    Grunig, Ekkehard
    Jerjes-Sanchez, Carlos
    Meyer, Gisela
    Pulido, Tomas
    Sepulveda, Pabo
    Wang, Kuo
    Deng, Chunqin
    Grover, Rob
    Ousmanou, Aliou
    Solum, Derek
    Tapson, Victor
    [J]. CHEST, 2019, 156 (04) : 1178A - 1179A
  • [9] Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Engel, Peter
    Bajwa, Abubakr
    Ravichandran, Ashwin
    Feldman, Jeremy
    Case, Amy Hajari
    Argula, Rahul G.
    Tapson, Victor
    Smith, Peter
    Deng, Chunqin
    Shen, Eric
    Nathan, Steven D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (06)
  • [10] PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Humbert, M.
    Mclaughlin, V. V.
    Gibbs, S. R.
    Gomberg-Maitland, M.
    Hoeper, M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Ghofrani, H. A.
    Subias, P. Escribano
    Feldman, J. P.
    Bohns Meyer, G.
    Montani, D.
    Olsson, K. M.
    Manimaran, S.
    Pena, J. de Oliveira
    Badesch, D. B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345